ReviewJournal of clinical medicine2023

Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient's Subjective Quality of Life, Well-Being, and Satisfaction.

Claudio Brasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.